Quanterix, a privately-held maker of diagnostic tests, has raised $18.5 million Series C funding round, which includes a $15 million equity stake from new investor bioMerieux. Existing investors ARCH Venture Partners, Bain Capital Ventures and Flagship Ventures and In-Q-Tel, a non-profit strategic investor located in Arlington, Va., also took part.